Erratum for Grossman et al., Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic

Eitemau Tebyg

• Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
  gan: Grossman, Trudy H., et al.
  Cyhoeddwyd: (2012)
• Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
  gan: Sutcliffe, J. A., et al.
  Cyhoeddwyd: (2013)
• Eravacycline (TP-434) Is Active In Vitro against Biofilms Formed by Uropathogenic Escherichia coli
  gan: Grossman, Trudy H., et al.
  Cyhoeddwyd: (2015)
• Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens
  gan: Grossman, Trudy H., et al.
  Cyhoeddwyd: (2017)
• Eravacycline (TP-434) Is Efficacious in Animal Models of Infection
  gan: Grossman, Trudy H., et al.
  Cyhoeddwyd: (2015)